Zebra Technologies Corp. (NASDAQ:ZBRA)
ZBRA reported that it expects to report sales for the first quarter of 2014 in the range of $287,000,000 to $289,000,000, or 21% over the $236,937,000 in sales reported for the same period the prior year, while ZBRA's earnings are expected in a range of $0.79 to $0.82 per share, up approximately 74% from $0.46 per share for the first quarter of 2013.
ZBRA also announced that it will acquire Motorola's Enterprise business for $3.45 billion in an all-cash transaction.
ZBRA offers technologies that give a virtual voice to an organization's assets, people and transactions, enabling organizations to unlock greater business value.
Lannett Company, Inc. (NYSEMKT:LCI)
LCI reported that it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application for Diazepam Oral Solution (Concentrate), 5 mg/mL, a Schedule C-IV controlled drug.
Diazepam Oral Solution (Concentrate), 5 mg/mL, is therapeutically equivalent to the reference listed drug, Diazepam Intensol Oral Solution (Concentrate), 5 mg/mL, of Roxane Laboratories, Inc.
LCI develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of medical indications.
Read Full Disclaimer at www.pennyomega.com/disclaimer
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.